Outcomes of Patients with Relapsed Mantle Cell Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

被引：8
|
作者：
Sawalha, Yazeed
Goyal, Subir
Switchenko, Jeffrey M.
Romancik, Jason T.
Kamdar, Manali
Greenwell, Irl Brian
Hess, Brian T.
Isaac, Krista
Portell, Craig A.
Garcia, Alex V. Mejia
Goldsmith, Scott R.
Grover, Natalie S.
Riedell, Peter A.
Karmali, Reem
Burkart, Madelyn
Buege, Michael J.
Akhtar, Othman S.
Torka, Pallawi
Kumar, Anita
Hill, Brian T.
Kahl, Brad S.
Cohen, Jonathon B.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138878
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
    Sawalha, Yazeed
    Goyal, Subir
    Switchenko, Jeffrey M.
    Romancik, Jason T.
    Kamdar, Manali
    Greenwell, I. Brian
    Hess, Brian T.
    Isaac, Krista M.
    Portell, Craig A.
    Garcia, Alex Mejia
    Goldsmith, Scott
    Grover, Natalie S.
    Riedel, Peter A.
    Karmali, Reem
    Burkart, Madelyn
    Buege, Michael
    Akhtar, Othman
    Torka, Pallawi
    Kumar, Anita
    Hill, Brian T.
    Kahl, Brad S.
    Cohen, Jonathon B.
    [J]. BLOOD ADVANCES, 2023, 7 (13) : 2983 - 2993
  • [2] Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis
    Sawalha, Yazeed
    Sarosiek, Shayna R.
    Welkie, Rina Li
    Seif, Sherif
    Thapa, Shrinjaya
    Zanwar, Saurabh
    Cahill, Kirk
    Treitman, Rachel
    Shah, Haikoo
    Arora, Shagun
    Pongas, Georgios
    Winter, Allison
    Major, Ajay
    Riedell, Peter A.
    Palomba, Maria Lia
    Kapoor, Prashant
    Grajales-Cruz, Ariel F.
    Shain, Kenneth H.
    Thomas, Sheeba K.
    Castillo, Jorge J.
    [J]. BLOOD, 2023, 142
  • [3] Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis
    Yi, J. H.
    Kim, W. S.
    Kim, S. J.
    Yoon, D. H.
    Suh, C.
    Chang, M. H.
    Yang, D. H.
    Jo, J-C.
    Hyun, S. Y.
    Eom, H-S.
    Lee, J-O.
    Kwon, J. H.
    Han, S. H.
    Lee, S-S.
    Kwak, J-Y.
    Kim, S. H.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [4] A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
    Lee, Yong-Pyo
    Jung, Ye Ji
    Cho, Junhun
    Ko, Young Hyeh
    Kim, Won Seog
    Kim, Seok Jin
    Yoon, Sang Eun
    [J]. BLOOD RESEARCH, 2023, 58 (04) : 208 - 220
  • [5] Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
    Yi, Jun Ho
    Kim, Seok Jin
    Yoon, Dok Hyun
    Suh, Cheolwon
    Chang, Myung Hee
    Yang, Deok Hwan
    Jo, Jae-Cheol
    Hyun, Shin Young
    Eom, Hyeon-Seok
    Lee, Jeong-Ok
    Kwon, Ji Hyun
    Han, Sang Hoon
    Lee, Seung-Shin
    Kwak, Jae-Yong
    Kim, Se Hyung
    Kim, Dae Sik
    Lee, Ji Hyun
    Oh, Sung Yong
    Ryoo, Hun Mo
    Kim, Hyo Jung
    Kim, Won Seog
    [J]. CANCER COMMUNICATIONS, 2021, 41 (03) : 275 - 278
  • [6] Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel
    Romancik, Jason T.
    Goyal, Subir
    Gerson, James N.
    Ballard, Hatcher J.
    Sawalha, Yazeed
    Bond, David A.
    Rogalski, Michael Joseph
    Greenwell, Irl Brian
    van Besien, Koen
    Yamshon, Samuel
    Karmali, Reem
    Nizamuddin, Imran
    Torka, Pallawi
    Chow, Victor A.
    Shadman, Mazyar
    Ghosh, Nilanjan
    Moyo, Tamara K.
    Fenske, Timothy S.
    Rezazadeh, Alexandra
    Grover, Natalie S.
    Maddocks, Kami J.
    Jacobson, Caron
    Cohen, Jonathon B.
    [J]. BLOOD, 2021, 138
  • [7] Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
    Jain, Preetesh
    Zhao, Shuangtao
    Kanagal-Shamanna, Rashmi
    Navsaria, Lucy
    Ok, Chi Young
    Zhang, Shaojun
    Nomie, Krystle
    Han, Guangchun
    Hao, Dapeng
    Hill, Holly A.
    Jiang, Changying
    Yao, Yixin
    Nastoupil, Loretta
    Westin, Jason
    Fayad, Luis
    Nair, Ranjit
    Steiner, Raphel
    Ahmed, Sairah
    Samaniego, Felipe
    Iyer, Swaminathan P.
    Oriabure, Onyeka
    Chen, Wendy
    Song, Xingzhi
    Zhang, Jianhua
    Badillo, Maria
    Moghrabi, Omar
    Tang, Guilin
    Yin, C. Cameron
    Patel, Keyur
    Medeiros, Leonard Jeffrey
    Li, Shaoying
    Vega, Francisco
    Thirumurthi, Selvi
    Xu, Guofan
    Neelapu, Sattva
    Flowers, Christopher R.
    Romaguera, Jorge
    Fowler, Nathan
    Wang, Linghua
    Wang, Michael L.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : 623 - 629
  • [8] Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma
    Wallace, Danielle S.
    Rowland, Chris
    Hill, Brian T.
    Baran, Andrea M.
    Casulo, Carla
    Reagan, Patrick M.
    Winter, Allison
    Karmali, Reem
    Winter, Jane N.
    Gordon, Leo I.
    Bui, Andrew
    Sportelli, Peter
    Miskin, Hari P.
    Weiss, Michael S.
    Friedberg, Jonathan W.
    Ma, Shuo
    Barr, Paul M.
    [J]. LEUKEMIA & LYMPHOMA, 2023,
  • [9] Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
    Jain, Preetesh
    Kanagal-Shamanna, Rashmi
    Zhang, Shaojun
    OK, Chi Young
    Navsaria, Lucy
    Nastoupil, Loretta
    Lee, Hun Ju
    Tang, Guilin
    Yin, C. Cameron
    Badillo, Maria
    Nair, Ranjit
    Li, Shaoying
    Patel, Keyur M.
    Flowers, Christopher
    Vega, Francisco
    Wang, Linghua
    Wang, Michael L.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E137 - E140
  • [10] Retrospective analysis of treatment patterns and outcomes with subcutaneous (SQ) bortezomib (BTZ) in patients (pts) with relapsed mantle cell lymphoma (MCL).
    Bonthapally, Vijayveer
    Lafeuille, Marie-Helene
    Fortier, Jonathan
    Duh, Mel Sheng
    Ng, Yvette
    Van De Velde, Helgi
    Niculescu, Liviu
    Ma, Esprit
    Goy, Andre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345